The challenge of painful crisis in sickle cell disease.
Nagel
R L
RL
D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000503:physiopathology; D006401:Hematologic Agents / Q000627:therapeutic use*; D006801:Humans; D010146:Pain / Q000209:etiology / Q000517:prevention & control*; D020442:Poloxamer / Q000627:therapeutic use*
D006401:Hematologic Agents; D020442:Poloxamer